The Organization of Future Medicine (General Incorporated Foundation Future Medicine Promotion Organization) has announced an extension of the application deadline for Global Startup Support – Discover Stage, an entrepreneurship and early-stage research development accelerator based at Nakanoshima Qross in Osaka, Japan. The program supports startups and researchers working in drug discovery, biotechnology, and regenerative medicine, helping transform promising scientific research into commercially viable ventures with global growth potential. Applications opened on 14 September 2026, and the deadline has been extended to 30 October 2026.
Program Overview: Global Startup Support – Discover Stage
- Program Name: Global Startup Support – Discover Stage
- Operating Organization: Organization of Future Medicine (General Incorporated Foundation Future Medicine Promotion Organization)
- Location: Nakanoshima Qross, Osaka, Japan
- Target Sectors: Health & Life Sciences, AI & Data, DeepTech
- Target Startup Stages: Ideation, Pre-seed, Seed
- Program Categories: Accelerator, Training & Learning
- Target Participants: Early-stage life sciences startups, university researchers, research institutions, and entrepreneurs developing promising scientific discoveries
- Application Deadline: 30 October 2026
- Program Objective: Identify, develop, and commercialize promising research innovations in drug discovery and regenerative medicine.
The initiative aims to strengthen Japan's life sciences startup ecosystem by helping researchers and early-stage ventures advance scientific discoveries, generate critical research data, develop business capabilities, and prepare for international commercialization.
Support Programs
Global Startup Support – Discover Stage offers two distinct acceleration tracks tailored to the development needs of participating startups and researchers.
Support A: AI Acceleration and Nonclinical Data Accumulation Support
Implementation Partners: Alloy Therapeutics Inc. and xCARE Inc.
This track supports early-stage life sciences ventures seeking to strengthen their scientific evidence, research development strategies, and investment readiness.
Key Support Areas:
- AI-powered acceleration to improve research development strategies and investor readiness.
- Guidance from specialized life sciences experts on research design and experimental planning.
- Nonclinical data generation and accumulation through wet-laboratory research.
- Expert assistance to strengthen scientific validation and commercialization potential.
- Support in preparing promising drug discovery technologies for further development and potential investment.
Target Participants: Early-stage biotechnology and drug discovery startups requiring additional scientific validation, nonclinical evidence, and expert technical guidance.
Support B: Lecture-Based and Practical Acceleration Program
Implementation Partner: BioLabs Academy LLC.
This track is designed for researchers, academic innovators, and newly established startups developing promising discoveries in the life sciences.
Key Support Areas:
- Educational sessions covering startup formation and life sciences commercialization.
- Practical acceleration activities focused on transforming research discoveries into business opportunities.
- Guidance on developing foundational business and entrepreneurial capabilities.
- Support for commercialization planning and international market readiness.
- Access to expertise and insights from international biotechnology startup ecosystems.
- Preparation for future research development, fundraising, and global expansion.
Target Participants: University researchers, academic research institutions, scientists with early-stage research discoveries, and newly established biotechnology startups.
Program Partners
Alloy Therapeutics Inc.
Alloy Therapeutics is a biotechnology company originating in the United States that provides drug discovery technology platforms and scientific capabilities to support pharmaceutical research, development, and commercialization.
xCARE Inc.
xCARE supports organizations operating in medical and life sciences industries by providing specialized expertise across research, development, and commercialization.
BioLabs Academy LLC.
BioLabs Academy develops educational and acceleration initiatives for biotechnology entrepreneurs and academic researchers, helping promising academic drug discovery projects progress toward clinical development and commercialization.
Eligibility and Target Participants
Global Startup Support – Discover Stage focuses on emerging innovators operating in the drug discovery and regenerative medicine sectors.
The program is particularly relevant to:
- Researchers at universities and academic institutions developing promising scientific discoveries.
- Entrepreneurs exploring the commercialization of biotechnology and life sciences research.
- Newly established startups developing drug discovery technologies or regenerative medicine solutions.
- Early-stage ventures seeking expert support to strengthen scientific validation and research development.
- Startups preparing for future fundraising, commercialization, and international expansion.
The program primarily supports Ideation, Pre-seed, and Seed-stage opportunities, although eligibility requirements may differ between Support A and Support B.
Benefits and Opportunities
Participating startups and researchers may benefit from:
- Scientific Development Support: Technical guidance for advancing promising drug discovery and regenerative medicine research.
- AI and Research Optimization: AI-related acceleration support and expert-led research planning through Support A.
- Nonclinical Research Support: Assistance with generating scientific evidence and research data through laboratory activities.
- Entrepreneurial Training: Practical education covering commercialization strategies, venture creation, and business development.
- Expert Mentorship: Guidance from professionals experienced in biotechnology research and life sciences commercialization.
- Global Commercialization Readiness: Preparation for future engagement with overseas biotechnology ecosystems, investors, pharmaceutical companies, and potential business partners.
- Ecosystem Access: Opportunities to connect with expertise and networks associated with Nakanoshima Qross and its collaborating organizations.
The type and extent of support depend on the selected program track.
Application Process
Applications are submitted online through the official recruitment process.
Application Details:
- Application Opening Date: 14 September 2026
- Extended Application Deadline: 30 October 2026
- Application Method: Online application
- Available Tracks: Support A and Support B
- Application Requirements: Applicants must review the official recruitment guidelines and select the most appropriate support track.
About Nakanoshima Qross
Nakanoshima Qross is an international future medicine innovation hub based in Osaka, Japan. The hub brings together stakeholders from industry, government, academia, and healthcare to accelerate the development, practical application, and commercialization of medical innovations, with particular emphasis on regenerative medicine, drug discovery, and emerging life sciences technologies.
About the Drug Discovery Cluster Campus Development Project
The Discover Stage initiative forms part of broader drug discovery ecosystem development activities centered on Nakanoshima Qross. These activities are supported through the Innovative Pharmaceuticals Practical Application Support Fund, managed by the National Institutes of Biomedical Innovation, Health and Nutrition (NIBN) under Japan's Ministry of Health, Labour and Welfare. The project aims to establish an integrated ecosystem that supports promising academic discoveries and startup innovations from early research and development through practical application.
Researchers, entrepreneurs, and early-stage startups developing innovations in drug discovery and regenerative medicine are encouraged to apply to Global Startup Support – Discover Stage before the extended deadline. Through its two specialized acceleration tracks, the program offers opportunities to strengthen scientific development, build commercialization capabilities, receive expert guidance, and prepare promising biotechnology innovations for future international growth.